PLSE
Pulse Biosciences, Inc Common Stock (DE)
stockNASDAQ
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 52.32 | 2026-09-28 | -8.37% | -1.459 |
| 1M | 53.24 | 2026-09-04 | -9.96% | -0.341 |
| 3M | 29.11 | 2026-07-06 | +64.69% | 1.020 |
| 6M | 22.94 | 2026-04-06 | +108.98% | 1.273 |
| 1Y | 19.29 | 2025-10-03 | +148.52% | 2.019 |
| 2Y | 15.98 | 2024-10-04 | +200.00% | — |
| 5Y | 20.33 | 2021-10-04 | +135.81% | 1.398 |
Pulse Biosciences, Inc Common Stock (DE) (NASDAQ:PLSE) stock price today is $47.94, and today's volume is 519,265. PLSE is down 3.793% today. The 30 day average volume is 614,100. PLSE market cap is $3.42B with 71.32M shares outstanding.